FDA Issues Guidance on Endpoints for Opioid MATs

Drug sponsors may not have to prove that a proposed medicine-assisted therapy helps addicts completely kick opioids but they will have to detail how well it helps cut dependence to win FDA approval, the agency said in a new draft guidance.
Source: International Pharmaceutical Regulatory Monitor